| Literature DB >> 26735129 |
Yu Wang1,2, Yang Lv1, Shujun Gao3, Yuanyuan Zhang3, Jiajia Sun1, Chunling Gong1, Xiujuan Chen2, Guangpeng Li1.
Abstract
To comparatively analyze the human microRNA (miRNA) profiles between spontaneous decidualized menstrual endometrium and early pregnancy decidua by an in-depth sequencing of miRNAs. The specific miRNAs expressed at conception might be involved in pregnancy establishment and expression of let-7f-5p and let-7g-5p was experimentally up-regulated or inhibited to assess the effect on the expression of IGF2BP-1 and IGF2R in vitro, respectively. Samples of endometria and deciduas were obtained from 25 women who suffered from tubal or male factor subfertility and from 35 early pregnant women who underwent pregnancy termination at 6-8 weeks gestation were irrespectively collected and comparatively analyzed by miRNA sequencing and differential expression of known and novel miRNAs was analyzed using bioinformatics. The 2042 miRNA expression was analyzed in the study and the differential expression of six miRNAs was validated by qRT-PCR. The expression of four miRNAs in decidua samples was down-regulated (miR-34c, miR-92a, miR-181a-5p, and miR-191), whereas the expression of miR-10a-5p and let-7f-5p was significantly up-regulated. The expression of IGF2BP-1 and IGF2R declined and increased with overexpression and inhibition of let-7f-5p and let-7g-5p, respectively. Changes in the expression of particular miRNAs might play a role in the physiology of decidualization following successful embryo implantation, ultimately resulting in continuous decidualization.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26735129 PMCID: PMC4703305 DOI: 10.1371/journal.pone.0143116
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Validation of the differential expression of six known miRNAs by qPCR analysis.
The miRNA expression level was normalized to that of U6 snRNA. “*” represents P value <0.05, “**” represents P value <0.01, and “***” represents P value <0.001. All experiments were repeated with 3 replicates.
The 62 novel miRNAs expressed in the human decidua and menstrual endometrium.
Candidates with sequence overlap with known miRNAs (but having a distinct mature miRNA sequence: isomiRs) and sequence alignments of novel miRNA candidates with known miRNAs of other species are shown.
| Reads (Normalized) | |||||
|---|---|---|---|---|---|
| Novel miRNA | Sequence | Chromosome | early pregnancy | menstrual endometrium | P_value |
| novel_mir_126 | chr6:168714989:168715066:- | 0 | 1.3 | 0.36 | |
| novel_mir_131 | chr1:149711776:149711867:- | 0 | 1.21 | 0.36 | |
| novel_mir_73 | chr1:43830309:43830391:- | 2.7 | 12.18 | 0.11 | |
| novel_mir_117 | chr3:25706352:25706437:- | 0 | 1.69 | 0.36 | |
| novel_mir_48 | chr5:64332325:64332403:+ | 7.6 | 2.92 | 0.34 | |
| novel_mir_110 | chr20:30194978:30195067:+ | 0 | 6.14 | 0.03 | |
| novel_mir_11 | chr22:31556037:31556127:- | 55.7 | 49.63 | 0.41 | |
| novel_mir_8 | chr19:58024375:58024442:- | 0 | 6.69 | 0.22 | |
| novel_mir_3 | chr11:16984501:16984581:- | 54.4 | 20.58 | 0.16 | |
| novel_mir_125 | chr2:208832756:208832839:- | 0 | 3.38 | 0.36 | |
| novel_mir_4 | chr11:125757935:125758025:- | 0 | 1.19 | 0.36 | |
| novel_mir_124 | chr22:50747028:50747103:- | 0 | 3.13 | 0.18 | |
| novel_mir_101 | chr8:144897778:144897866:- | 1.6 | 5.68 | 0.34 | |
| novel_mir_52 | chr6:42071607:42071696:- | 4.32 | 4.89 | 0.90 | |
| novel_mir_26 | chr9:35710651:35710743:- | 5.35 | 20.54 | 0.24 | |
| novel_mir_34 | chr9:35710651:35710743:- | 14.6 | 6 | 0.34 | |
| novel_mir_109 | chr1:17215841:17215936:- | 0 | 3.08 | 0.17 | |
| novel_mir_87 | chr2:85935673:85935771:- | 11.2 | 12.59 | 0.92 | |
| novel_mir_129 | chr8:141538823:141538913:- | 0 | 2.62 | 0.36 | |
| novel_mir_114 | chr17:7754252:7754345:+ | 0 | 0.84 | 0.36 | |
| novel_mir_115 | chr1:145397811:145397885:- | 0 | 1.18 | 0.36 | |
| novel_mir_116 | chr1:150533203:150533277:- | 0 | 0.84 | 0.36 | |
| novel_mir_119 | chr12:125424204:125424296:- | 0 | 2.61 | 0.36 | |
| novel_mir_113 | chr5:171831829:171831908:- | 0 | 3.29 | 0.36 | |
| novel_mir_128 | chr15:93541625:93541715:+ | 0 | 1.31 | 0.36 | |
| novel_mir_62 | chr20:3194750:3194836:+ | 0 | 5.16 | 0.22 | |
| novel_mir_123 | chrUn_gl000220:156679:156752:+ | 0 | 3.79 | 0.36 | |
| novel_mir_123 | chrUn_gl000220:112707:112780:+ | 0 | 3.79 | 0.36 | |
| novel_mir_19 | chr6:5148472:5148552:+ | 31.2 | 2.76 | 0.13 | |
| novel_mir_120 | chr16:30198328:30198410:+ | 0 | 1.42 | 0.36 | |
| novel_mir_51 | chr6_mann_hap4:222225:222307:+ | 1393 | 265 | 0.09 | |
| novel_mir_51 | chr6_qbl_hap6:222220:222302:+ | 1393 | 265 | 0.09 | |
| novel_mir_51 | chr6:28918820:28918902:+ | 1393 | 265 | 0.09 | |
| novel_mir_51 | chr6_ssto_hap7:259727:259809:+ | 1393 | 265 | 0.09 | |
| novel_mir_51 | chr6_mcf_hap5:222373:222455:+ | 1393 | 265 | 0.09 | |
| novel_mir_51 | chr6_cox_hap2:437556:437638:+ | 1393 | 265 | 0.09 | |
| novel_mir_21 | chr7:100240307:100240383:- | 0 | 2.7 | 0.18 | |
| novel_mir_118 | chr3:184970973:184971071:- | 0 | 0.84 | 0.36 | |
| novel_mir_121 | chr19:1253351:1253436:+ | 0 | 1.19 | 0.36 | |
| novel_mir_122 | chr1:28573676:28573749:- | 0 | 1.9 | 0.36 | |
| novel_mir_38 | chr3:53797063:53797141:+ | 0 | 1.9 | 0.36 | |
| novel_mir_108 | chr14:55587747:55587820:+ | 0 | 1.26 | 0.36 | |
| novel_mir_23 | chr8:79679467:79679541:+ | 20.7 | 18.92 | 0.79 | |
| novel_mir_12 | chr2:85935674:85935771:- | 0 | 48.52 | 0.04 | |
| novel_mir_83 | chr1:17215843:17215929:- | 6.55 | 1.52 | 0.18 | |
| novel_mir_33 | chr6:42071607:42071696:- | 3.22 | 1.3 | 0.47 | |
| novel_mir_130 | chr11:125757934:125758033:- | 0 | 1.21 | 0.36 | |
| novel_mir_112 | chr5:167592851:167592932:+ | 0 | 1.26 | 0.36 | |
| novel_mir_127 | chr10:3436634:3436717:+ | 0 | 2.62 | 0.36 | |
| novel_mir_17 | chr5:171831829:171831908:- | 0 | 2.7 | 0.36 | |
| novel_mir_32 | chr6_qbl_hap6:253423:253493:+ | 4.9 | 8.45 | 0.64 | |
| novel_mir_32 | chr6_mann_hap4:253429:253499:+ | 4.9 | 8.45 | 0.64 | |
| novel_mir_32 | chr6_dbb_hap3:253437:253507:+ | 4.9 | 8.45 | 0.64 | |
| novel_mir_32 | chr6_cox_hap2:468829:468899:+ | 4.9 | 8.45 | 0.64 | |
| novel_mir_32 | chr6:28950026:28950096:+ | 4.9 | 8.45 | 0.64 | |
| novel_mir_32 | chr6_ssto_hap7:290997:291067:+ | 4.9 | 8.45 | 0.64 | |
| novel_mir_32 | chr6_apd_hap1:253428:253498:+ | 4.9 | 8.45 | 0.64 | |
| novel_mir_25 | chr9:135927378:135927447:+ | 0 | 2.78 | 0.36 | |
| novel_mir_64 | chr2:219206629:219206708:+ | 0 | 3.32 | 0.36 | |
| novel_mir_132 | chr1:153585537:153585627:- | 0 | 1.45 | 0.36 | |
| novel_mir_14 | chr3:45730469:45730561:- | 49.6 | 118.58 | 0.20 | |
| novel_mir_97 | chr3:45883723:45883820:+ | 1.6 | 3.52 | 0.42 | |
| novel_mir_20 | chr6_ssto_hap7:259726:259810:+ | 473 | 1109.78 | 0.30 | |
| novel_mir_20 | chr6_cox_hap2:437555:437639:+ | 473 | 1109.78 | 0.30 | |
| novel_mir_20 | chr6_mcf_hap5:222372:222456:+ | 473 | 1109.78 | 0.30 | |
| novel_mir_20 | chr6_qbl_hap6:222219:222303:+ | 473 | 1109.78 | 0.30 | |
| novel_mir_20 | chr6_mann_hap4:222224:222308:+ | 473 | 1109.78 | 0.30 | |
| novel_mir_20 | chr6:28918819:28918903:+ | 473 | 1109.78 | 0.30 | |
| novel_mir_100 | chr6:6152173:6152249:- | 2.06 | 1.66 | 0.88 | |
| novel_mir_28 | chr15:45493361:45493452:+ | 28.6 | 18.18 | 0.49 | |
| novel_mir_15 | chr3:127294107:127294180:- | 2.06 | 2.57 | 0.85 | |
| novel_mir_82 | chr19:2762628:2762702:- | 1.31 | 2.82 | 0.51 | |
| novel_mir_111 | chr3:127294100:127294179:- | 0 | 3.03 | 0.36 | |
| novel_mir_133 | chr5:137810882:137810978:- | 0 | 2.9 | 0.36 | |
| novel_mir_30 | chr2:113994290:113994372:- | 40.2 | 8.9 | 0.35 | |
| novel_mir_24 | chr8:141538823:141538913:- | 5.36 | 13.11 | 0.36 | |
| novel_mir_74 | chr20:17486149:17486232:+ | 1.57 | 6.45 | 0.11 | |
| novel_mir_1 | chr5:57745034–57745054:- | 16.5464 | 0 | 0.01 | |
| novel_mir_18 | chr3:51385333–51385354:+ | 10.0535 | 0 | <0.01 | |
Fig 2Kyoto Encyclopedia of Genes and Genomes analysis indicating the number of miRNA-targeted genes and the various associated pathways.
Horizontal axis indicates the annotated signaling pathways identified, and the vertical axis indicates the number of genes in each pathway to which miRNAs were predicted to bind.
Fig 3(a) Let-7f-5p was predicted to bind to a site on the IGF2BP-1 mRNA. (b) Let-7g-5p was predicted to bind to a site on the IGF-2R mRNA.
Fig 4IGF2BP-1 expression in vitro after overexpression or knockdown of let-7f-5p.
(a) Overexpression of let-7f-5p in HEK293T and hESCs cells. Cells were cultured and incubated with hsa-let-7f-5p mimic or negative control. Levels of let-7f-5p were determined using qPCR. (b) Knockdown of let-7f miRNA by transfection with hsa-let-7f-5p inhibitor. Cells were cultured and incubated with hsa-let-7f-5p inhibitor or negative control. Levels of let-7f-5p were determined using qPCR. (c-d) Expression of IGF2BP-1 mRNA, as determined using qPCR analysis. Experiments were replicated three times, and error bars represent standard error. **P<0.01, ***P<0.001.
Fig 5IGF2R expression in vitro after overexpression or knockdown of let-7g-5p.
(a) Overexpression of let-7g-5p in HEK293T and hESCs cells. Cells were cultured and incubated with let-7g-5p mimic or negative control. Levels of let-7g-5p were determined using qPCR. (b) Knockdown of let-7g-5p miRNA by transfection with hsa-let-7g-5p inhibitor. Cells were cultured and incubated with hsa-let-7g-5p inhibitor or negative control. Levels of let-7g-5p were determined using qPCR. (c-d) Expression of IGF2R mRNA, as determined using qPCR analysis. Experiments were replicated three times, and error bars represent standard error. *P<0.05, **P<0.01 ***P<0.001.